REGENEREX PHARMA, INC.

RGPXSEC EDGAR

Pharmaceutical Preparations(NV)CIK: 1357878

Concept	FY2024	FY2023	FY2022	FY2020	FY2019
Revenues	—	—	—	$2.6K	$2.6K
Cost of Goods and Services Sold	—	—	—	$1.7K	—
Gross Profit	—	—	—	$896.00	$896.00
Research and Development Expense	$2.4M	$2.4M	—	—	—
Selling, General and Administrative Expense	$1.1M	—	—	—	—
Operating Expenses	$3.5M	$96.2K	$43.4K	$77.9K	$91.7K
Operating Income (Loss)	-$3.5M	-$96.2K	-$43.4K	-$77.0K	-$91.7K
Interest Expense	$80.6K	$66.8K

Concept	FY2024	FY2023	FY2022	FY2020	FY2019
Assets	$766.7K	$6.5K	$10.5K	$259.2K	$105.6K
Assets, Current	$2.9K	$1.1K	$8.1K	$252.2K	$97.6K
Cash and Cash Equivalents, at Carrying Value	$372.00	$1.1K	$5.5K	$88.5K	$1.7K
Inventory, Net	—	—	—	$246.7K	$246.7K
Liabilities	$4.8M	$1.1M	$845.5K	$740.4K	$475.3K
Liabilities, Current	$3.8M	$776.8K	$621.3K	$518.7K	$405.3K
Long-term Debt, Excluding Current Maturities	$184.2K	$184.2K	—	—	—

Concept	FY2024	FY2023	FY2022	FY2020	FY2019
Net Cash Provided by (Used in) Operating Activities	-$457.5K	-$76.2K	-$62.7K	-$291.2K	$47.1K
Net Cash Provided by (Used in) Investing Activities	-$6.3K	-$1.4K	-$8.6K	-$6.0K	-$6.0K
Net Cash Provided by (Used in) Financing Activities	$463.1K	$76.1K	$64.1K	$214.1K	$133.9K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)